Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Predict S.P.A. Class B ( (IT:PRE) ) has provided an announcement.
Predict S.p.A.’s Board of Directors has approved the 2026 corporate events calendar and initiated a program for purchasing and disposing of own shares, appointing Integrae SIM S.p.A. as the intermediary. This strategic move may enhance Predict’s market operations and investor relations, reflecting its commitment to maintaining transparency and shareholder value.
The most recent analyst rating on (IT:PRE) stock is a Buy with a EUR1.45 price target. To see the full list of analyst forecasts on Predict S.P.A. Class B stock, see the IT:PRE Stock Forecast page.
More about Predict S.P.A. Class B
Predict S.p.A., founded in 2008 in Bari, is an innovative SME in the med-tech sector focusing on in vivo diagnostics. The company operates through four Strategic Business Units: Imaging and People Support for diagnostic imaging, Mistral for breath analysis, and Digital Healthcare for augmented reality and robotics solutions. Predict has developed technologies like Mistral for non-invasive cancer screening, Aphel for AI in hospitals, and Optip for remote medical consultation. It collaborates with major Italian research institutes and universities and has offices in Bari and Milan.
Average Trading Volume: 29,462
Technical Sentiment Signal: Strong Buy
Current Market Cap: €6.12M
Find detailed analytics on PRE stock on TipRanks’ Stock Analysis page.